Biofrontera Inc. (BFRI) Stock

Healthcare · Drug Manufacturers - Specialty & Generic · Member of Other US Stocks

Biofrontera Inc. (BFRI) closed at USD 0.83 on 2026-10-14, a change of -21.7 % over the past year, with a market capitalization of USD 12.58M.

Biofrontera Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Biofrontera Inc. key figures

Previous close

USD 0.83 (2026-10-14)

1-year change

-21.7 %

Market cap

USD 12.58M

Enterprise value

USD 15.42M

P/E ratio (trailing)

-2.07

P/E ratio (forward)

1.97

EPS (trailing)

-0.41

EPS (forward)

0.43

PEG ratio

n/a

Price to book

2.02

Revenue growth

32.9 %

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

0.21

Employees

84

Analyst consensus (third-party)

none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Biofrontera Inc.

Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Biofrontera Inc. and compare it with other stocks.